Clinical Trial Update: Maintenance Bevacizumab or Observation After Taxane Based First Line Chemotherapy In Metastatic Breast Cancer

View source ↗

Summary

A completed randomized trial evaluating maintenance bevacizumab versus observation after taxane-based first-line chemotherapy in metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Hellenic Oncology Research Group | Conditions: Metastatic Breast Cancer | Status: COMPLETED